Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−512,740−100.0%Sold outHolders
Q1 2026512,740$7.41M<0.1%−746,485−59.3%ReducedHolders
Q4 20251,259,225$17.9M<0.1%+797,255+172.6%AddedHolders
Q3 2025461,970$3.64M<0.1%−841,994−64.6%ReducedHolders
Q2 20251,303,964$7.47M<0.1%−1,357,430−51.0%ReducedHolders
Q1 20252,661,394$21.7M<0.1%+105,856+4.1%AddedHolders
Q4 20242,555,538$24.1M<0.1%+5,480+0.2%AddedHolders
Q3 20242,550,058$27.2M<0.1%−2,955−0.1%ReducedHolders
Q2 20242,553,013$25.3M<0.1%+1,787,125+233.3%AddedHolders
Q1 2024765,888$9.02M<0.1%+600,212+362.3%AddedHolders
Q4 2023165,676$2.35M<0.1%−752,043−81.9%ReducedHolders
Q3 2023917,719$11.2M<0.1%+150,641+19.6%AddedHolders
Q2 2023767,078$9.63M<0.1%−165,651−17.8%ReducedHolders
Q1 2023932,729$10.3M<0.1%+111,630+13.6%AddedHolders
Q4 2022821,099$10.0M<0.1%+95,155+13.1%AddedHolders
Q3 2022725,944$7.58M<0.1%+566,417+355.1%AddedHolders
Q2 2022159,527$1.71M<0.1%+7,395+4.9%AddedHolders
Q1 2022152,132$1.44M<0.1%−6,587−4.2%ReducedHolders
Q4 2021158,719$1.83M<0.1%−10,814−6.4%ReducedHolders
Q3 2021169,533$1.62M<0.1%+20,439+13.7%AddedHolders
Q2 2021149,094$1.44M<0.1%+34,432+30.0%AddedHolders
Q1 2021114,662$1.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.